公开(公告)号：EP4374875A1

公开(公告)日：2024-05-29

申请号：EP22845446.8

申请日：2022-07-22

申请人： CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.

发明人： LUO, Suxia ,  LI, Ning ,  MA, Yijie ,  BIE, Liangyu ,  LI, Jiajun

IPC分类号： A61K39/395 ,  A61K31/4709 ,  A61P35/00

CPC分类号： A61K39/395 ,  A61P35/00 ,  A61K31/4709

摘要： A combination drug for treatment of gastric carcinoma and/or esophagogastric junction cancer, comprising an anti-PD-L1 antibody and anlotinib or a pharmaceutically acceptable salt thereof. The combination drug further comprises at least one third therapeutic agent. In addition, the present application further provides a use of a combination drug or a pharmaceutic composition, which comprises an anti-PD-L1 antibody and anlotinib or a pharmaceutically acceptable salt thereof, in preparation of a drug for treatment of gastric carcinoma and/or esophagogastric junction cancer.